Change Language

Select Language

COVID-19
The pandemic continues to cause unprecedented disruption across industries worldwide.
Get detailed insights regarding the impact of COVID-19 on the market.

Prostate Cancer Treatment Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2022-2027

Market Overview:

The global prostate cancer treatment market size reached US$ 6.81 Billion in 2021. Looking forward, IMARC Group expects the market to reach US$ 10.09 Billion by 2027, exhibiting a growth rate (CAGR) of 6.32% during 2022-2027. Keeping in mind the uncertainties of COVID-19, we are continuously tracking and evaluating the direct as well as the indirect influence of the pandemic. These insights are included in the report as a major market contributor.

Prostate cancer is a type of severe malignant tumor, which is caused by the uncontrollable division and expansion of various abnormal cells in the prostate gland present in men. It can be treated through the use of various therapeutics, such as vaccines, medications, and treatments. Amongst these, chemotherapy, immunotherapy, cryotherapy, surgery, hormonal, targeted and radiation therapy are some of the most common treatment types that aid in mitigating the spread of cancer cells in the body. These therapies are provided to the patient based on various assessments, such as the age of the patient, severity of the symptoms experienced, medical condition, and previous health history. 

Prostate Cancer Treatment Market Trends:

The increasing prevalence of prostate cancer, especially amongst the rising geriatric population, is one of the prime factors currently driving the market toward growth. In line with this, the availability of favorable medical reimbursement policies and the numerous initiatives being undertaken by the government bodies of several countries for introducing patient assistance programs (PAPs) are acting as other growth-inducing factors. PAP is an organized program, which is controlled by pharmaceutical companies for providing financial assistance to patients by offering free medications for treatment purposes. Moreover, significant technological advancements, such as the integration of multiparametric-magnetic resonance imaging (mp-MRI) devices with non-metastatic castration-resistant (nmCRPC) and metastatic hormone nave (mHNPC) settings for detecting prostate cancer at early stages, while mitigating diagnostic errors, is also contributing to the market growth. Additionally, extensive investments in the research and development (R&D) activities to introduce novel therapeutic products, along with their easy availability across various online and offline distribution channels, are creating a positive outlook for the market. 

Key Market Segmentation:

IMARC Group provides an analysis of the key trends in each sub-segment of the global prostate cancer treatment market report, along with forecasts at the global, regional and country level from 2022-2027. Our report has categorized the market based on drug type and distribution channel.

Breakup by Drug Type:

  • Chemotherapy
  • Biological Therapy
  • Hormone Therapy
  • Others
     

Breakup by Distribution Channel:

  • Hospitals Pharmacies
  • Drug Stores and Retail Pharmacies
  • Online Pharmacies
     

Breakup by Region:

  • North America
    • United States
    • Canada
  • Asia-Pacific
    • China
    • Japan
    • India
    • South Korea
    • Australia
    • Indonesia
    • Others
  • Europe
    • Germany
    • France
    • United Kingdom
    • Italy
    • Spain
    • Russia
    • Others
  • Latin America
    • Brazil
    • Mexico
    • Others
  • Middle East and Africa
     

Competitive Landscape:

The competitive landscape of the industry has also been examined along with the profiles of the key players being Astellas Pharma Inc., AstraZeneca plc, Bayer Aktiengesellschaft, Dendreon Pharmaceuticals LLC. (Sanpower Group Co. Ltd.), F. Hoffmann-La Roche AG, Ferring B.V., GlaxoSmithKline Plc, Ipsen (Mayroy SA), Novartis International AG, Takeda Pharmaceutical Company Ltd. and Tolmar Pharmaceuticals Inc.

Report Coverage:

Report Features Details
Base Year of the Analysis 2021
    Historical Period 2016-2021
Forecast Period 2022-2027
Units US$ Billion
Segment Coverage Drug Type, Distribution Channel, Region
Region Covered  Asia Pacific, Europe, North America, Latin America, Middle East and Africa
Countries Covered United States, Canada, Germany, France, United Kingdom, Italy, Spain, Russia, China, Japan, India, South Korea, Australia, Indonesia, Brazil, Mexico
Companies Covered Astellas Pharma Inc., AstraZeneca plc, Bayer Aktiengesellschaft, Dendreon Pharmaceuticals LLC. (Sanpower Group Co. Ltd.), F. Hoffmann-La Roche AG, Ferring B.V., GlaxoSmithKline Plc, Ipsen (Mayroy SA), Novartis International AG, Takeda Pharmaceutical Company Ltd. and Tolmar Pharmaceuticals Inc.
Customization Scope 10% Free Customization
Report Price and Purchase Option Single User License: US$ 2499
Five User License: US$ 3499
Corporate License: US$ 4499
Post-Sale Analyst Support 10-12 Weeks
Delivery Format PDF and Excel through Email (We can also provide the editable version of the report in PPT/Word format on special request)

 

Key Questions Answered in This Report:

  • How has the global prostate cancer treatment market performed so far and how will it perform in the coming years?
  • What has been the impact of COVID-19 on the global prostate cancer treatment market?
  • What are the key regional markets?
  • What is the breakup of the market based on the drug type?
  • What is the breakup of the market based on the distribution channel?
  • What are the various stages in the value chain of the industry?
  • What are the key driving factors and challenges in the industry?
  • What is the structure of the global prostate cancer treatment market and who are the key players?
  • What is the degree of competition in the industry?

1    Preface
2    Scope and Methodology

    2.1    Objectives of the Study
    2.2    Stakeholders
    2.3    Data Sources
        2.3.1    Primary Sources
        2.3.2    Secondary Sources
    2.4    Market Estimation
        2.4.1    Bottom-Up Approach
        2.4.2    Top-Down Approach
    2.5    Forecasting Methodology
3    Executive Summary
4    Introduction

    4.1    Overview
    4.2    Key Industry Trends
5    Global Prostate Cancer Treatment Market
    5.1    Market Overview
    5.2    Market Performance
    5.3    Impact of COVID-19
    5.4    Market Forecast
6    Market Breakup by Drug Type 
    6.1    Chemotherapy
        6.1.1 Market Trends
        6.1.2 Market Forecast
    6.2    Biological Therapy
        6.2.1 Market Trends
        6.2.2 Market Forecast
    6.3    Hormone Therapy
        6.3.1 Market Trends
        6.3.2 Market Forecast
    6.4    Others
        6.4.1 Market Trends
        6.4.2 Market Forecast
7    Market Breakup by Distribution Channel 
    7.1    Hospitals Pharmacies
        7.1.1 Market Trends
        7.1.2 Market Forecast
    7.2    Drug Stores and Retail Pharmacies
        7.2.1 Market Trends
        7.2.2 Market Forecast
    7.3    Online Pharmacies
        7.3.1 Market Trends
        7.3.2 Market Forecast
8    Market Breakup by Region
    8.1    North America
        8.1.1 United States
           8.1.1.1 Market Trends
           8.1.1.2 Market Forecast
        8.1.2 Canada
           8.1.2.1 Market Trends
           8.1.2.2 Market Forecast
    8.2    Asia-Pacific
        8.2.1 China
           8.2.1.1 Market Trends
           8.2.1.2 Market Forecast
        8.2.2 Japan
           8.2.2.1 Market Trends
           8.2.2.2 Market Forecast
        8.2.3 India
           8.2.3.1 Market Trends
           8.2.3.2 Market Forecast
        8.2.4 South Korea
           8.2.4.1 Market Trends
           8.2.4.2 Market Forecast
        8.2.5 Australia
           8.2.5.1 Market Trends
           8.2.5.2 Market Forecast
        8.2.6 Indonesia
           8.2.6.1 Market Trends
           8.2.6.2 Market Forecast
        8.2.7 Others
           8.2.7.1 Market Trends
           8.2.7.2 Market Forecast
    8.3    Europe
        8.3.1 Germany
           8.3.1.1 Market Trends
           8.3.1.2 Market Forecast
        8.3.2 France
           8.3.2.1 Market Trends
           8.3.2.2 Market Forecast
        8.3.3 United Kingdom
           8.3.3.1 Market Trends
           8.3.3.2 Market Forecast
        8.3.4 Italy
           8.3.4.1 Market Trends
           8.3.4.2 Market Forecast
        8.3.5 Spain
           8.3.5.1 Market Trends
           8.3.5.2 Market Forecast
        8.3.6 Russia
           8.3.6.1 Market Trends
           8.3.6.2 Market Forecast
        8.3.7 Others
           8.3.7.1 Market Trends
           8.3.7.2 Market Forecast
    8.4    Latin America
        8.4.1 Brazil
           8.4.1.1 Market Trends
           8.4.1.2 Market Forecast
        8.4.2 Mexico
           8.4.2.1 Market Trends
           8.4.2.2 Market Forecast
        8.4.3 Others
           8.4.3.1 Market Trends
           8.4.3.2 Market Forecast
    8.5    Middle East and Africa
        8.5.1 Market Trends
        8.5.2 Market Breakup by Country
        8.5.3 Market Forecast
9    SWOT Analysis
    9.1    Overview
    9.2    Strengths
    9.3    Weaknesses
    9.4    Opportunities
    9.5    Threats
10    Value Chain Analysis
11    Porters Five Forces Analysis

    11.1    Overview
    11.2    Bargaining Power of Buyers
    11.3    Bargaining Power of Suppliers
    11.4    Degree of Competition
    11.5    Threat of New Entrants
    11.6    Threat of Substitutes
12    Price Analysis
13    Competitive Landscape

    13.1    Market Structure
    13.2    Key Players
    13.3    Profiles of Key Players
        13.3.1    Astellas Pharma Inc.
           13.3.1.1 Company Overview
           13.3.1.2 Product Portfolio
           13.3.1.3 Financials
           13.3.1.4 SWOT Analysis
        13.3.2    AstraZeneca plc
           13.3.2.1 Company Overview
           13.3.2.2 Product Portfolio
           13.3.2.3 Financials
           13.3.2.4 SWOT Analysis
        13.3.3    Bayer Aktiengesellschaft
           13.3.3.1 Company Overview
           13.3.3.2 Product Portfolio
           13.3.3.3 Financials
           13.3.3.4 SWOT Analysis
        13.3.4    Dendreon Pharmaceuticals LLC. (Sanpower Group Co. Ltd.)
           13.3.4.1 Company Overview
           13.3.4.2 Product Portfolio
        13.3.5    F. Hoffmann-La Roche AG
           13.3.5.1 Company Overview
           13.3.5.2 Product Portfolio
           13.3.5.3 Financials
        13.3.6    Ferring B.V.
           13.3.6.1 Company Overview
           13.3.6.2 Product Portfolio
        13.3.7    GlaxoSmithKline Plc
           13.3.7.1 Company Overview
           13.3.7.2 Product Portfolio
           13.3.7.3 Financials
           13.3.7.4 SWOT Analysis
        13.3.8    Ipsen (Mayroy SA)
           13.3.8.1 Company Overview
           13.3.8.2 Product Portfolio
           13.3.8.3 Financials
           13.3.8.4 SWOT Analysis
        13.3.9    Novartis International AG
           13.3.9.1 Company Overview
           13.3.9.2 Product Portfolio
           13.3.9.3 Financials
           13.3.9.4 SWOT Analysis
        13.3.10    Takeda Pharmaceutical Company Ltd.
           13.3.10.1 Company Overview
           13.3.10.2 Product Portfolio
           13.3.10.3 Financials
           13.3.10.4 SWOT Analysis
        13.3.11    Tolmar Pharmaceuticals Inc. 
           13.3.11.1 Company Overview
           13.3.11.2 Product Portfolio

List of Figures

Figure 1: Global: Prostate Cancer Treatment Market: Major Drivers and Challenges
Figure 2: Global: Prostate Cancer Treatment Market: Sales Value (in Billion US$), 2016-2021
Figure 3: Global: Prostate Cancer Treatment Market Forecast: Sales Value (in Billion US$), 2022-2027
Figure 4: Global: Prostate Cancer Treatment Market: Breakup by Drug Type (in %), 2021
Figure 5: Global: Prostate Cancer Treatment Market: Breakup by Distribution Channel (in %), 2021
Figure 6: Global: Prostate Cancer Treatment Market: Breakup by Region (in %), 2021
Figure 7: Global: Prostate Cancer Treatment (Chemotherapy) Market: Sales Value (in Million US$), 2016 & 2021
Figure 8: Global: Prostate Cancer Treatment (Chemotherapy) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 9: Global: Prostate Cancer Treatment (Biological Therapy) Market: Sales Value (in Million US$), 2016 & 2021
Figure 10: Global: Prostate Cancer Treatment (Biological Therapy) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 11: Global: Prostate Cancer Treatment (Hormone Therapy) Market: Sales Value (in Million US$), 2016 & 2021
Figure 12: Global: Prostate Cancer Treatment (Hormone Therapy) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 13: Global: Prostate Cancer Treatment (Other Drug Types) Market: Sales Value (in Million US$), 2016 & 2021
Figure 14: Global: Prostate Cancer Treatment (Other Drug Types) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 15: Global: Prostate Cancer Treatment (Hospitals Pharmacies) Market: Sales Value (in Million US$), 2016 & 2021
Figure 16: Global: Prostate Cancer Treatment (Hospitals Pharmacies) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 17: Global: Prostate Cancer Treatment (Drug Stores and Retail Pharmacies) Market: Sales Value (in Million US$), 2016 & 2021
Figure 18: Global: Prostate Cancer Treatment (Drug Stores and Retail Pharmacies) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 19: Global: Prostate Cancer Treatment (Online Pharmacies) Market: Sales Value (in Million US$), 2016 & 2021
Figure 20: Global: Prostate Cancer Treatment (Online Pharmacies) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 21: North America: Prostate Cancer Treatment Market: Sales Value (in Million US$), 2016 & 2021
Figure 22: North America: Prostate Cancer Treatment Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 23: United States: Prostate Cancer Treatment Market: Sales Value (in Million US$), 2016 & 2021
Figure 24: United States: Prostate Cancer Treatment Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 25: Canada: Prostate Cancer Treatment Market: Sales Value (in Million US$), 2016 & 2021
Figure 26: Canada: Prostate Cancer Treatment Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 27: Asia-Pacific: Prostate Cancer Treatment Market: Sales Value (in Million US$), 2016 & 2021
Figure 28: Asia-Pacific: Prostate Cancer Treatment Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 29: China: Prostate Cancer Treatment Market: Sales Value (in Million US$), 2016 & 2021
Figure 30: China: Prostate Cancer Treatment Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 31: Japan: Prostate Cancer Treatment Market: Sales Value (in Million US$), 2016 & 2021
Figure 32: Japan: Prostate Cancer Treatment Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 33: India: Prostate Cancer Treatment Market: Sales Value (in Million US$), 2016 & 2021
Figure 34: India: Prostate Cancer Treatment Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 35: South Korea: Prostate Cancer Treatment Market: Sales Value (in Million US$), 2016 & 2021
Figure 36: South Korea: Prostate Cancer Treatment Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 37: Australia: Prostate Cancer Treatment Market: Sales Value (in Million US$), 2016 & 2021
Figure 38: Australia: Prostate Cancer Treatment Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 39: Indonesia: Prostate Cancer Treatment Market: Sales Value (in Million US$), 2016 & 2021
Figure 40: Indonesia: Prostate Cancer Treatment Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 41: Others: Prostate Cancer Treatment Market: Sales Value (in Million US$), 2016 & 2021
Figure 42: Others: Prostate Cancer Treatment Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 43: Europe: Prostate Cancer Treatment Market: Sales Value (in Million US$), 2016 & 2021
Figure 44: Europe: Prostate Cancer Treatment Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 45: Germany: Prostate Cancer Treatment Market: Sales Value (in Million US$), 2016 & 2021
Figure 46: Germany: Prostate Cancer Treatment Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 47: France: Prostate Cancer Treatment Market: Sales Value (in Million US$), 2016 & 2021
Figure 48: France: Prostate Cancer Treatment Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 49: United Kingdom: Prostate Cancer Treatment Market: Sales Value (in Million US$), 2016 & 2021
Figure 50: United Kingdom: Prostate Cancer Treatment Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 51: Italy: Prostate Cancer Treatment Market: Sales Value (in Million US$), 2016 & 2021
Figure 52: Italy: Prostate Cancer Treatment Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 53: Spain: Prostate Cancer Treatment Market: Sales Value (in Million US$), 2016 & 2021
Figure 54: Spain: Prostate Cancer Treatment Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 55: Russia: Prostate Cancer Treatment Market: Sales Value (in Million US$), 2016 & 2021
Figure 56: Russia: Prostate Cancer Treatment Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 57: Others: Prostate Cancer Treatment Market: Sales Value (in Million US$), 2016 & 2021
Figure 58: Others: Prostate Cancer Treatment Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 59: Latin America: Prostate Cancer Treatment Market: Sales Value (in Million US$), 2016 & 2021
Figure 60: Latin America: Prostate Cancer Treatment Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 61: Brazil: Prostate Cancer Treatment Market: Sales Value (in Million US$), 2016 & 2021
Figure 62: Brazil: Prostate Cancer Treatment Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 63: Mexico: Prostate Cancer Treatment Market: Sales Value (in Million US$), 2016 & 2021
Figure 64: Mexico: Prostate Cancer Treatment Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 65: Others: Prostate Cancer Treatment Market: Sales Value (in Million US$), 2016 & 2021
Figure 66: Others: Prostate Cancer Treatment Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 67: Middle East and Africa: Prostate Cancer Treatment Market: Sales Value (in Million US$), 2016 & 2021
Figure 68: Middle East and Africa: Prostate Cancer Treatment Market: Breakup by Country (in %), 2021
Figure 69: Middle East and Africa: Prostate Cancer Treatment Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 70: Global: Prostate Cancer Treatment Industry: SWOT Analysis
Figure 71: Global: Prostate Cancer Treatment Industry: Value Chain Analysis
Figure 72: Global: Prostate Cancer Treatment Industry: Porter's Five Forces Analysis

List of Tables

Table 1: Global: Prostate Cancer Treatment Market: Key Industry Highlights, 2021 and 2027
Table 2: Global: Prostate Cancer Treatment Market Forecast: Breakup by Drug Type (in Million US$), 2022-2027
Table 3: Global: Prostate Cancer Treatment Market Forecast: Breakup by Distribution Channel (in Million US$), 2022-2027
Table 4: Global: Prostate Cancer Treatment Market Forecast: Breakup by Region (in Million US$), 2022-2027
Table 5: Global: Prostate Cancer Treatment Market: Competitive Structure
Table 6: Global: Prostate Cancer Treatment Market: Key Players


Note: We value your privacy and will never rent or sell your email address. Privacy policy

Need more help?

  •   Speak to our experienced analysts for insights on the current market scenarios.
  •   Include additional segments and countries to customize the report as per your requirement.
  •   Gain an unparalleled competitive advantage in your domain by understanding how to utilize the report and positively impacting your operations and revenue.
  •   For further assistance, please connect with our analysts.

Purchase Options




$ 2499

REACH OUT TO US

Call us on

( US: +1-631-791-1145 )
( UK: +44-753-713-2163 )
( India: +91 120 433 0800 )


Drop us an email at

sales@imarcgroup.com

Social Links